MENU
+Compare
OZEM
ETF ticker: NASDAQ
AS OF
Dec 24 closing price
Price
$35.50
Change
+$0.25 (+0.71%)

OZEM stock forecast, quote, news & analysis

The investment seeks to provide capital appreciation... Show more

Category: #Health
OZEM
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for OZEM with price predictions
Dec 24, 2025

OZEM in +3.10% Uptrend, growing for three consecutive days on December 24, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where OZEM advanced for three days, in of 113 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 05, 2025. You may want to consider a long position or call options on OZEM as a result. In of 18 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for OZEM just turned positive on December 24, 2025. Looking at past instances where OZEM's MACD turned positive, the stock continued to rise in of 13 cases over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 62 cases where OZEM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OZEM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

OZEM broke above its upper Bollinger Band on December 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), AstraZeneca PLC (NASDAQ:AZN), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks to provide capital appreciation. The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.

Market Cap

The average market capitalization across the Roundhill GLP-1 & Weight Loss ETF ETF is 112.3B. The market cap for tickers in the group ranges from 415.28M to 963.92B. LLY holds the highest valuation in this group at 963.92B. The lowest valued company is ALT at 415.28M.

High and low price notable news

The average weekly price growth across all stocks in the Roundhill GLP-1 & Weight Loss ETF ETF was 6%. For the same ETF, the average monthly price growth was 9%, and the average quarterly price growth was 41%. GPCR experienced the highest price growth at 16%, while ALT experienced the biggest fall at -22%.

Volume

The average weekly volume growth across all stocks in the Roundhill GLP-1 & Weight Loss ETF ETF was -52%. For the same stocks of the ETF, the average monthly volume growth was -71% and the average quarterly volume growth was -58%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 77
Price Growth Rating: 44
SMR Rating: 68
Profit Risk Rating: 70
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
OZEM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details